Emodepside
Emodepside is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
Emodepside Phase II Trial for Treatment of Onchocerciasis
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Clinical Trials (5)
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
Emodepside Phase II Trial for Treatment of Onchocerciasis
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5